Clinical Trials
2 trialsNCT03038672 2026-05-12
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT01676805 2026-05-05
Tissue Collection for Studies of Lymph Cancer
National Institutes of Health Clinical Center (CC)
Recruiting